Theriva Biologics Inc (TOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Operating Expenses | 2,537 | 2,132 | 2,111 | 2,889 | 3,028 |
| Operating Income | -2,537 | -2,132 | -2,111 | -2,889 | -3,028 |
| Other Income | 0 | 0 | 0 | 6 | 38 |
| Pre-tax Income | -2,537 | -2,132 | -2,111 | -2,883 | -2,990 |
| Net Income Continuous | -2,537 | -2,132 | -2,111 | -2,883 | -2,990 |
| Minority Interests | 1 | -23 | -8 | -16 | -26 |
| Net Income | $-2,538 | $-2,109 | $-2,103 | $-2,867 | $-2,964 |
| EPS Basic Total Ops | -32.50 | -35.00 | -35.00 | -45.00 | -50.00 |
| EPS Basic Continuous Ops | -6.98 | -22.93 | -27.21 | -39.16 | -43.73 |
| EPS Diluted Total Ops | -32.50 | -35.00 | -35.00 | -45.00 | -50.00 |
| EPS Diluted Continuous Ops | -6.98 | -22.93 | -27.21 | -39.16 | -43.73 |
| EBITDA(a) | $-2,504 | $-2,100 | $-2,058 | $-2,831 | $-2,970 |